Arthrotec 50 · DIN 01917056 · 50 mg & 200 mcg · tablet
General benefitMarketed · checked November 17, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Savings card: RxHelp ONE lists Arthrotec (read 2026-09-10) — brand-name savings card, free; cannot be combined with another card on the same claim. (rxhelp.ca ↗)
1 brand, same coverage
Arthrotec 50 · DIN 01917056
Manufacturer: Pfizer Canada Inc.; listing date 1996-10-01
Health Canada: Marketed since 2005-11-21 · brand ARTHROTEC 50 · ATC M01AB55 DICLOFENAC, COMBINATIONS · form Tablet (delayed-release) · route Oral · ingredients DICLOFENAC SODIUM 50 MG, MISOPROSTOL 200 MCG · company Accudial pharmaceutical inc · schedule Prescription
Ministry pays: $0.3149 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 01917056)
Source record
DIN 01917056: Arthrotec 50
Raw flags: sec3=Y
Item: 280804049; group id 380; item number 0907; lccId None; manufacturer id PFI
Source form: Tab; strength: 50mg & 200mcg
Recorded listing: General benefit
Source prices (unrounded): $0.7788; ministry $0.3149
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=01917056
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13636
Therapeutic Notes (formulary)
NSAIDs have a high rate of serious adverse effects in the elderly. When prescribing NSAIDs, the minimal effective dose for the shortest period of time should be used. In nonspecific pain and/or osteoarthritis, in the absence of joint inflammation (swelling), acetaminophen is a better first choice for analgesia. The most effective treatment to prevent NSAID-gastritis is misoprostol; although H-2 antagonists, such as ranitidine or cimetidine, are commonly used, they are not as effective. NSAIDs can significantly aggravate hypertension and congestive heart failure; ASA in doses below 1 gram per day is a better choice than other NSAID options if anti-inflammatory effects are required in patients with these conditions. Low dose ASA has additional benefits for anti-platelet indications that are not provided by other NSAIDs, and should be given in preference or in addition to other NSAIDs for patients with vascular indications.
Interchangeable products
Gd-Diclofenac/Misoprostol 50 · DIN 02341689 · $0.3149
PMS-Diclofenac-Misoprostol · DIN 02413469 · $0.3149
Shortage status: not checked (no credentials)